Evans David Mark
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Sirnaomics Ltd. | 02257 | 12-Jul-21 | 20-Jun-24 | ED | AGM ordinary resolutions regarding, re-election was not passed. Dr. Evans will remain as the Head of Drug Discovery and Collaboration of the Group |